SM
NSPRZ

Sabby Management’s InspireMD, Inc. Series B Warrants NSPRZ Stock Holding History

Sabby Management’s Portfolio NSPRZ Stock Details NSPRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,067,324
Closed -$1K – 116
2019
Q1 		$1K Sell
1,067,324
-364,809
-25% -$438 ﹤0.01% 80
2018
Q4 		$2K Sell
1,432,133
-415,503
-22% -$1.12K ﹤0.01% 120
2018
Q3 		$7K Sell
1,847,636
-134,681
-7% -$1.21K ﹤0.01% 119
2018
Q2 		$36K Sell
1,982,317
-16,100
-0.8% -$312 0.01% 125
2018
Q1 		$30K Sell
1,998,417
-5,431
-0.3% -$150 ﹤0.01% 146
2017
Q4 		$40K Buy
2,003,848
+1,200
+0.1% +$33 ﹤0.01% 145
2017
Q3 		$40K Buy
2,002,648
+300
+0% +$26 ﹤0.01% 156
2017
Q2 		$155K Buy
+2,002,348
New +$262K 0.01% 186

Other funds holding NSPRZ

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Sabby Management's NSPRZ Position: Q2 2019 in Review

Sabby Management sold out of InspireMD, Inc. Series B Warrants (NSPRZ) in Q2 2019, closing a stake of 1,067,324 shares — an estimated $1K sold.

Sabby Management first reported a position in NSPRZ in Q2 2017 and held it in 8 quarters. The position peaked at $155K in Q2 2017. 4 funds tracked by Wall St. Rank hold NSPRZ as of Q2 2019.

  • Sabby Management reported no remaining InspireMD, Inc. Series B Warrants position as of Q2 2019 after selling out during the quarter.
  • Sabby Management sold 1,067,324 InspireMD, Inc. Series B Warrants shares in Q2 2019, an estimated $1K.
  • Sabby Management first reported a position in InspireMD, Inc. Series B Warrants in Q2 2017 and held it in 8 quarters.
  • Sabby Management's InspireMD, Inc. Series B Warrants position peaked at $155K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held InspireMD, Inc. Series B Warrants as of Q2 2019.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.